Evidence map›Paper›PMID 28298901›Full record

ArticleFrontiers in microbiology2017

Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases.

Lucia Mundo, Maria R Ambrosio, Matteo Picciolini, Giuseppe Lo Bello, Sara Gazaneo, Leonardo Del Porro, Stefano Lazzi, Mohsen Navari, Noel Onyango, Massimo Granai and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus.Frontiers in cellular and infection microbiology · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Lucia MundoSection of Pathology, Department of Medical Biotechnology, University of Siena Siena, Italy.
Maria R AmbrosioSection of Pathology, Department of Medical Biotechnology, University of Siena Siena, Italy.
Matteo PiccioliniDiatech Pharmacogenetics Jesi, Italy.
Giuseppe Lo BelloSection of Pathology, Department of Medical Biotechnology, University of Siena Siena, Italy.
Sara GazaneoSection of Pathology, Department of Medical Biotechnology, University of Siena Siena, Italy.
Leonardo Del PorroSection of Pathology, Department of Medical Biotechnology, University of Siena Siena, Italy.
Stefano LazziSection of Pathology, Department of Medical Biotechnology, University of Siena Siena, Italy.
Mohsen NavariDepartment of Experimental, Diagnostic, and Experimental Medicine, S. Orsola-Malpighi Hospital, Bologna University School of Medicine Bologna, Italy.
Noel OnyangoDepartment of Clinical Medicine and Therapeutics, University of Nairobi Nairobi, Kenya.
Massimo GranaiSection of Pathology, Department of Medical Biotechnology, University of Siena Siena, Italy.
Cristiana BellanSection of Pathology, Department of Medical Biotechnology, University of Siena Siena, Italy.
Giulia De FalcoSchool of Biological and Chemical Sciences, Queen Mary University of London London, UK.
Davide GibelliniVirology Unit, Department of Diagnostic and Public Health, University of Verona Verona, Italy.
Pier P PiccalugaDepartment of Experimental, Diagnostic, and Experimental Medicine, S. Orsola-Malpighi Hospital, Bologna University School of MedicineBologna, Italy; Euro-Mediterranean Institute of Science and TechnologyPalermo, Italy.
Lorenzo LeonciniSection of Pathology, Department of Medical Biotechnology, University of Siena Siena, Italy.
University of Siena · ITIstituto Euro Mediterraneo di Scienza e Tecnologia · ITPoliclinico S.Orsola-Malpighi · ITQueen Mary University of London · GBUniversity of Nairobi · KEUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epstein-Barr virus (EBV) is a gammaherpesvirus linked to a number of lymphoid and epithelial malignancies, including Burkitt lymphoma (BL) in which its frequency ranges from 30% in sporadic cases to 100% in the endemic ones. The possible contribution of EBV to BL pathogenesis is largely unknown. It has been suggested that EBV may be associated with all of the cases, including those diagnosed as EBV negative by a mechanism of

Indexed as

Burkitt lymphomaEpstein–Barr virushit-and-runmicroRNA expression profilingvaccines

Identifiers

PMID28298901
PMCPMC5331039
OpenAlexW2592058866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.